UBE2C and thyroid gland carcinoma: Besides the identification of potential hub genes and pathways associated with ACT, we still analyzed the expression levels of these hub genes in other histological subtypes of thyroid carcinoma and found that UBE2C gene expression did not significantly change in other thyroid carcinomas, suggesting that UBE2C might act as a specific diagnostic biomarker for ACT.